Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Tioga Pharmaceuticals, Inc. logo — company profile

Tioga Pharmaceuticals, Inc.

Founded 2005 1 employees Series B Total: $57.00M Biotechnology, Health and Wellness +1

General Information

Company Name Tioga Pharmaceuticals, Inc.
Founded Year 2005
Employees 1
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Series B
Social

Get notified when Tioga Pharmaceuticals, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Tioga Pharmaceuticals, Inc.

Tioga Pharmaceuticals, Inc. is a biotechnology startup founded in 2005 that specializes in the health and wellness industry, with a focus on pharmaceuticals. The company is currently in the planning stages for a phase 2 trial of its selective kappa-opioid receptor agonist, asimadoline, aimed at treating conditions associated with atopic pruritus. Their last significant funding round was a $10.00M Series B investment on 12 April 2012, which was led by Genesys Capital Management Inc and Thomas, McNerney & Partners. This upcoming trial and the support of these well-established investors positions Tioga Pharmaceuticals for potential growth and further success in the pharmaceutical industry.

Taxonomy: Tioga Pharmaceuticals, pharmaceuticals, clinical trial, phase 2 trial, selective kappa-opioid receptor agonist, asimadoline, atopic pruritus, drug development, medical research

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 2
Investor Investor
12 Apr 2012
Venture Round •••••• 4
Investor Investor Investor Investor
17 Feb 2010
Debt Financing •••••• - 23 Oct 2009
Debt Financing •••••• - 26 May 2009
Series A •••••• 3
Investor Investor Investor
09 Jan 2006

Tioga Pharmaceuticals, Inc. Alternatives & Competitors

Tioga Pharmaceuticals, Inc. vs
MacuCLEAR
MacuCLEAR

Pioneering innovative treatments for vascular eye disorders with promising clinical success.

Series Unknown
Biotechnology, Health Care
Tioga Pharmaceuticals, Inc. vs
CG Oncology
CG Oncology United States

Attacking Bladder Cancer for a Better Tomorrow

Series F
121 employees
Biotechnology, Health Care
Tioga Pharmaceuticals, Inc. vs
Data Magik Ltd
Data Magik Ltd United Kingdom

The clinical trial experts for Data Management and Statistics

13 employees
Data Analytics

FAQ About Tioga Pharmaceuticals, Inc.

Tioga Pharmaceuticals is planning to conduct a phase 2 trial of its selective kappa-opioid receptor agonist, asimadoline, for the treatment of associated with atopic pruritus.
Tioga Pharmaceuticals, Inc. was founded in 2005.
Tioga Pharmaceuticals, Inc. operates in the following industries: Biotechnology, Health and Wellness, Pharmaceutical.
Tioga Pharmaceuticals, Inc. has approximately 1 employees.
Tioga Pharmaceuticals, Inc. has completed 5 funding rounds, raising a total of $57.00M. The latest funding stage is Series B.
Top alternatives and competitors to Tioga Pharmaceuticals, Inc. include MacuCLEAR, CG Oncology, Data Magik Ltd, Climb, Dextra Laboratories . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Tioga Pharmaceuticals, Inc. and MacuCLEAR are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Tioga Pharmaceuticals, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes